UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Series A Preferred Stock | Â (4) | Â (5) | Common Stock | (6) | $ 0 | D | Â |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Canute Scott A C/O ONCOBIOLOGICS, INC. 7 CLARKE DRIVE CRANBURY, NJ 08521 |
 X |  |  |  |
/s/ Lawrence Kenyon, Attorney-in-Fact | 05/12/2016 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Granted pursuant to the Issuer's 2015 Equity Incentive Plan. |
(2) | Each restricted stock unit ("RSU") represents the right to receive, at settlement, one (1) share of the Issuer's common stock. |
(3) | The RSUs vest upon the first to occur of (x) a change of control as defined in the award agreement and (y) the expiration of the 6 month lock-up period following the Issuer's initial public offering ("IPO"), in each case subject to continued service through such event. |
(4) | N/A |
(5) | There is no expiration date. |
(6) | The reporting person holds 351 shares of Series A Preferred Stock. Such shares of Series A Preferred Stock will automatically convert into that number of shares of the Issuer's common stock immediately prior to the closing of the Issuer's IPO based on dividing the aggregate liquidation preference of $351,000 by the IPO price per share of common stock included in the units sold in the IPO. |